Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 908
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +5.9%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.4 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (459)

clinicaltrialsPublishedShowing 1,401–1,404 of 1,404 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00149565	Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma	completed	Phase 3	268	National Health Research Institutes, TaiwanOTHER	1	Dec 16, 2005	clinicaltrials
NCT00234182	Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC	completed	Phase 1 / Phase 2	84	The University of Hong KongOTHER	0	Dec 1, 2005	clinicaltrials